why choose us

First received: October 24, 2022

Clinical Trial: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: B-cell Malignancy

Study Type: INTERVENTIONAL


Official Title: A Phase 1b Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Brief Summary: This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 in patients with CLL/SLL or B-cell NHL who have failed or are intolerant to ?2 lines of systemic therapy.

Read more